在 Huntsman 在家,一个新型瘤医院在家计划中的成本和利用结果
Brock O'Neil1, Kassandra Dindinger-Hill1, Hailie Gill1
1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Journal of the American Medical Directors Association
|August 4, 2023
概括
"在家的猎人"计划减少了癌症患者在各个子组的医疗保健利用率和成本. 这种瘤医院在家模式提供了一致的好处,提高了护理质量和效率.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 医疗保健管理的管理
背景情况:
- 在家的猎人计划是一个新的瘤医院在家服务.
- 之前的研究表明,该计划减少了医疗保健利用率和成本.
- 目前的研究调查了特定患者子组的计划影响.
研究的目的:
- 评估"在家猎人"计划在不同患者小组中的有效性.
- 根据性别,年龄,收入,并发症和治疗状况分析对医疗保健利用和成本的影响.
主要方法:
- 使用电子健康数据进行回顾性病例控制研究.
- 对比了169名"猎人在家"患者和198名常规护理患者 (2018年8月至2019年10月).
- 分析的子组:性别,年龄 (≥65vs <65),收入 (≥$78,735vs <$78,735),查尔森并发症指数 (≥2vs <2) 和全身抗癌疗法使用.
主要成果:
- 在家的猎人显著降低了30天的费用,住院时间长度,意外住院和急救诊所的访问.
- 在所有研究子组中,至少在两个结果中观察到统计学上显著的好处 (P < .05).
- 没有一个子组表明他们更喜欢常规护理而不是"猎人在家"计划.
结论:
- 猎人在家计划在广泛的癌症患者小组中展示了一致的成本和利用效益.
- 家庭医院模式对于提高癌症护理质量和效率是有效的.
- 应考虑这种方法来优化癌症患者的管理.
相关概念视频
Cancer Survival Analysis
384
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
384
Documentation in Long-Term and Home Healthcare Setting
922
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
922
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Continuing Care
1.5K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K


